NV.BC.04

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameNV.BC.04
Drug Alias NameN/A
ClassificationSmall molecules > Lipid
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsInflammatory Bowel DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNanovector Srl
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNanovector Srl
Active IndicationsN/A
Inactive IndicationsInflammatory Bowel DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A